These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 31404850)

  • 1. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot randomized clinical trial of mindfulness-oriented recovery enhancement as an adjunct to methadone treatment for people with opioid use disorder and chronic pain: Impact on illicit drug use, health, and well-being.
    Cooperman NA; Hanley AW; Kline A; Garland EL
    J Subst Abuse Treat; 2021 Aug; 127():108468. PubMed ID: 34134880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pain, hedonic regulation, and opioid misuse: Modulation of momentary experience by Mindfulness-Oriented Recovery Enhancement in opioid-treated chronic pain patients.
    Garland EL; Bryan CJ; Finan PH; Thomas EA; Priddy SE; Riquino MR; Howard MO
    Drug Alcohol Depend; 2017 Apr; 173 Suppl 1():S65-S72. PubMed ID: 28363322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial.
    Garland EL; Recasens M; Taple BJ; Donaldson GW; Weisberg RB
    Ann Med; 2024 Dec; 56(1):2392870. PubMed ID: 39172534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telehealth Mindfulness-Oriented Recovery Enhancement vs Usual Care in Individuals With Opioid Use Disorder and Pain: A Randomized Clinical Trial.
    Cooperman NA; Lu SE; Hanley AW; Puvananayagam T; Dooley-Budsock P; Kline A; Garland EL
    JAMA Psychiatry; 2024 Apr; 81(4):338-346. PubMed ID: 38061786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using ecological momentary assessment to examine the relationship between craving and affect with opioid use in a clinical trial of clonidine as an adjunct medication to buprenorphine treatment.
    Kowalczyk WJ; Moran LM; Bertz JW; Phillips KA; Ghitza UE; Vahabzadeh M; Lin JL; Epstein DH; Preston KL
    Am J Drug Alcohol Abuse; 2018; 44(5):502-511. PubMed ID: 29634425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mindfulness-Oriented Recovery Enhancement vs Supportive Group Therapy for Co-occurring Opioid Misuse and Chronic Pain in Primary Care: A Randomized Clinical Trial.
    Garland EL; Hanley AW; Nakamura Y; Barrett JW; Baker AK; Reese SE; Riquino MR; Froeliger B; Donaldson GW
    JAMA Intern Med; 2022 Apr; 182(4):407-417. PubMed ID: 35226053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress, craving and mood as predictors of early dropout from opioid agonist therapy.
    Panlilio LV; Stull SW; Kowalczyk WJ; Phillips KA; Schroeder JR; Bertz JW; Vahabzadeh M; Lin JL; Mezghanni M; Nunes EV; Epstein DH; Preston KL
    Drug Alcohol Depend; 2019 Sep; 202():200-208. PubMed ID: 31357121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mindfulness-Oriented Recovery Enhancement reduces opioid craving, pain, and negative affect among chronic pain patients on long-term opioid therapy: An analysis of within- and between-person state effects.
    Parisi A; Hanley AW; Garland EL
    Behav Res Ther; 2022 May; 152():104066. PubMed ID: 35248875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dispositional mindfulness and prescription opioid misuse among chronic pain patients: Craving and attention to positive information as mediating mechanisms.
    Priddy SE; Hanley AW; Riquino MR; Platt KA; Baker AK; Garland EL
    Drug Alcohol Depend; 2018 Jul; 188():86-93. PubMed ID: 29754031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mindfulness-oriented recovery enhancement reduces opioid misuse risk via analgesic and positive psychological mechanisms: A randomized controlled trial.
    Garland EL; Hanley AW; Riquino MR; Reese SE; Baker AK; Salas K; Yack BP; Bedford CE; Bryan MA; Atchley R; Nakamura Y; Froeliger B; Howard MO
    J Consult Clin Psychol; 2019 Oct; 87(10):927-940. PubMed ID: 31556669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain, psychological flexibility, and continued substance use in a predominantly hispanic adult sample receiving methadone treatment for opioid use disorder.
    Rosen KD; Curtis ME; Potter JS
    Drug Alcohol Depend; 2020 Jan; 206():107681. PubMed ID: 31711875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craving mediates the association between momentary pain and illicit opioid use during treatment for opioid-use disorder: an ecological momentary assessment study.
    Mun CJ; Finan PH; Epstein DH; Kowalczyk WJ; Agage D; Letzen JE; Phillips KA; Preston KL
    Addiction; 2021 Jul; 116(7):1794-1804. PubMed ID: 33220102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial.
    Garland EL; Nakamura Y; Bryan CJ; Hanley AW; Parisi A; Froeliger B; Marchand WR; Donaldson GW
    Am J Psychiatry; 2024 Feb; 181(2):125-134. PubMed ID: 38196335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary measurement and mindfulness-based modulation of prescription opioid cue-reactivity.
    Hanley AW; Garland EL
    Drug Alcohol Depend; 2020 Dec; 217():108351. PubMed ID: 33070057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder.
    Freet CS; Evans B; Brick TR; Deneke E; Wasserman EJ; Ballard SM; Stankoski DM; Kong L; Raja-Khan N; Nyland JE; Arnold AC; Krishnamurthy VB; Fernandez-Mendoza J; Cleveland HH; Scioli AD; Molchanow A; Messner AE; Ayaz H; Grigson PS; Bunce SC
    Addict Sci Clin Pract; 2024 Jul; 19(1):56. PubMed ID: 39061093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using ecological momentary assessments of negative affect and craving during residential opioid use disorder treatment to predict patients' relapse to substance use.
    Cleveland HH; Knapp KS; Cleveland MJ; Deneke E; Bunce SC
    J Subst Use Addict Treat; 2023 Mar; 146():208931. PubMed ID: 36880896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Before and after: craving, mood, and background stress in the hours surrounding drug use and stressful events in patients with opioid-use disorder.
    Preston KL; Kowalczyk WJ; Phillips KA; Jobes ML; Vahabzadeh M; Lin JL; Mezghanni M; Epstein DH
    Psychopharmacology (Berl); 2018 Sep; 235(9):2713-2723. PubMed ID: 29980821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of Web-Based Single-Session Empowered Relief in Patients With Chronic Pain Taking Methadone or Buprenorphine: Protocol for a Single-Arm Trial.
    Klein MR; Darnall BD; You DS
    JMIR Res Protoc; 2024 Jun; 13():e53784. PubMed ID: 38843513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurophysiological evidence for remediation of reward processing deficits in chronic pain and opioid misuse following treatment with Mindfulness-Oriented Recovery Enhancement: exploratory ERP findings from a pilot RCT.
    Garland EL; Froeliger B; Howard MO
    J Behav Med; 2015 Apr; 38(2):327-36. PubMed ID: 25385024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.